Igor Bado
Impact in
- Oncology top 10%
- Cancer Cells and Metastasis
- Bone health and treatments
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation
Papers in
- Oncology 12
- Bone health and treatments 5
- Cancer-related Molecular Pathways 4
- Cytokine Signaling Pathways and Interactions 2
- Cancer Cells and Metastasis 2
- HER2/EGFR in Cancer Research 2
-
- Retinoids in leukemia and cellular processes 2
- Co-authors
- Xiang H.-F. Zhang (6 shared papers)Weijie Zhang (5 shared papers)Hai Wang (4 shared papers)Yang Gao (1 shared paper)Jeffrey M. Rosen (1 shared paper)Christoforos Thomas (6 shared papers)Fotis Nikolos (6 shared papers)Jan-Ακε Gustafsson (5 shared papers)
- Journals
- Molecular Cancer Research (2 papers)Oncotarget (2 papers)Oncogene (2 papers)Trends in cancer (1 paper)Cancer Cell (1 paper)
- Partner nations
- United StatesSwedenIran
In The Last Decade
Igor Bado
16 papers receiving 684 citations
Igor Bado's Hit Papers
Peers
Comparison fields: 5 of 76
- Oncology 388
- Cancer Research 184
- Molecular Biology 331
- Cell Biology 67
- Pulmonary and Respiratory Medicine 119
Countries citing papers authored by Igor Bado
This map shows the geographic impact of Igor Bado's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Igor Bado with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Igor Bado more than expected).
Fields of papers citing papers by Igor Bado
This network shows the impact of papers produced by Igor Bado. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Igor Bado. The network helps show where Igor Bado may publish in the future.
Co-authors
The 25 scholars most cited alongside Igor Bado, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Metastasis Organotropism: Redefining the Congenial Soil Hit paper breakdown → | 2019 | 259 |
| 2 | 2018 | 102 | |
| 3 | 2019 | 70 | |
| 4 | 2014 | 44 | |
| 5 | 2016 | 37 | |
| 6 | 2017 | 37 | |
| 7 | 2021 | 30 | |
| 8 | 2017 | 20 | |
| 9 | 2024 | 19 | |
| 10 | 2018 | 17 | |
| 11 | 2017 | 16 | |
| 12 | 2014 | 16 | |
| 13 | 2019 | 16 | |
| 14 | 2022 | 4 | |
| 15 | 2022 | 2 | |
| 16 | 2024 | 1 |
About Igor Bado
Igor Bado is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Genetics, having authored 16 papers that have together received 690 indexed citations. Recurring topics across this work include Bone health and treatments (5 papers), Cancer-related Molecular Pathways (4 papers), Medical Imaging and Pathology Studies (3 papers), Radiopharmaceutical Chemistry and Applications (3 papers), Cytokine Signaling Pathways and Interactions (2 papers), Cancer Cells and Metastasis (2 papers), HER2/EGFR in Cancer Research (2 papers) and Retinoids in leukemia and cellular processes (2 papers). The work is most often cited by research in Oncology (388 citations), Cancer Research (184 citations), Molecular Biology (331 citations), Cell Biology (67 citations) and Pulmonary and Respiratory Medicine (119 citations). Igor Bado has collaborated with scholars based in United States, Sweden and Iran. Frequent co-authors include Xiang H.-F. Zhang, Weijie Zhang, Hai Wang, Yang Gao, Jeffrey M. Rosen, Christoforos Thomas, Fotis Nikolos, Jan-Ακε Gustafsson, Zbigniew Gugala and Suzanne A.W. Fuqua. Their work appears in journals such as Molecular Cancer Research, Oncotarget, Oncogene, Trends in cancer and Cancer Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.